JP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $10
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
JP Morgan analyst John Stansel maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and lowers the price target from $22 to $10.
JP Morgan analyst John Stansel maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and lowers the price target from $22 to $10.